$Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study$

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2021-01, Vol.35 (1), p.235-238
Hauptverfasser:	Gentile, Massimo, Morabito, Fortunato, Del Poeta, Giovanni, Mauro, Francesca Romana, Reda, Gianluigi, Sportoletti, Paolo, Laurenti, Luca, Coscia, Marta, Herishanu, Yair, Recchia, Anna Grazia, Varettoni, Marzia, Murru, Roberta, Chiarenza, Annalisa, Condoluci, Adalgisa, Moia, Riccardo, Pietrasanta, Daniela, Loseto, Giacomo, Consoli, Ugo, Scortechini, Ilaria, Rossi, Francesca Maria, Zucchetto, Antonella, Fraticelli, Vincenzo, Vigna, Ernesto, Botta, Cirino, Tripepi, Giovanni, Arrigo, Graziella D’, Rago, Angela, Angeletti, Ilaria, Biagi, Annalisa, Del Giudice, Ilaria, Bomben, Riccardo, Rigolin, Gian Matteo, Rossi, Davide, Di Raimondo, Francesco, Gaidano, Gianluca, Polliack, Aaron, Cuneo, Antonio, Foà, Robin, Gattei, Valter
Format:	Artikel
Sprache:	eng
Schlagworte:	692/499 692/699/1541/1990/283/1895 Adenine - administration & dosage Adenine - adverse effects Adenine - analogs & derivatives Adenine - therapeutic use Anemia Antineoplastic Agents, Immunological - administration & dosage Antineoplastic Agents, Immunological - adverse effects Antineoplastic Agents, Immunological - therapeutic use Cancer Research Chronic lymphocytic leukemia Clinical medicine Clinical trials Critical Care Medicine Development and progression Drug therapy Drugs Evaluation Hematology Hemoglobin Humans Immunotherapy Inhibitor drugs Intensive Internal Medicine Letter Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - mortality Lymphatic leukemia Medicine Medicine & Public Health Molecular Targeted Therapy Mortality Multivariate analysis Oncology Piperidines - administration & dosage Piperidines - adverse effects Piperidines - therapeutic use Prognosis Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Targeted cancer therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0887-6924 1476-5551
DOI:	10.1038/s41375-020-0833-x